Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
metastatic RCC
.
Show all posts
Showing posts with label
metastatic RCC
.
Show all posts
Tuesday, August 25, 2015
First-line axitinib ‘feasible’ in advanced, metastatic RCC
›
We know that, Axitinib (AG013736; trade name Inlyta) is a small molecule tyrosine kinase inhibitor developed by Pfizer. It has bee...
›
Home
View web version
